Related Experiment Video
Updated: Aug 8, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Interferon-mediated activation of the STAT signaling pathway in a human carcinoid tumor
S Wang1, S K Tyring, C M Townsend
1Department of Surgery, People's Hospital, Beijing Medical University, China.
Background:
Growth inhibition of human cancers (e.g., endocrine tumors) by interferons (IFNs) has been demonstrated, but the exact cellular mechanisms remain largely undefined. IFNs and other cytokines can activate novel Stat (Signal transducers and activators of transcription) proteins, which translocate to the nucleus to activate target genes. The purpose of this study was to determine the effect of IFN-alpha and IFN-gamma on the Stat pathway using a unique human pancreatic carcinoid tumor, BON, established in our laboratory.
Methods:
BON cells were treated with IFN-alpha (500 U/mL) or IFN-gamma (500 U/mL); nuclear protein was extracted at selected intervals. Steady state levels of Stat proteins 1, 3, and 5 were measured by Western blot; protein binding was assessed by electrophoretic mobility shift assay (EMSA) using probes containing either the Stat1/Stat3 or Stat5 binding sites.
Results:
Treatment with IFN-alpha increased predominantly Stat3 and Stat5 protein levels and binding activities. IFN-gamma increased Stat1, 3, and 5 protein levels, with maximal elevations occurring at 24 to 48 hours after addition; Stat3 and 5 binding activities were also increased.
Conclusions:
We have shown that both IFN-alpha and IFN-gamma can induce Stat protein binding (particularly Stat3 and Stat5) to their cognate DNA consensus sites and increase Stat protein steady state levels in BON cells. Delineating the signaling pathways altered by IFN treatment will provide a better understanding of downstream gene targets and mechanisms for IFN-mediated growth inhibition of endocrine tumors.
Insights
Interferons (IFNs) activate Signal Transducers and Activators of Transcription (Stat) proteins, influencing human cancer growth. This study shows IFNs increase Stat protein levels and DNA binding in pancreatic carcinoid tumor cells.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Interferons (IFNs) inhibit human cancers, including endocrine tumors, but mechanisms are unclear.
- IFNs activate Signal Transducers and Activators of Transcription (Stat) proteins, which regulate gene expression.
- Understanding these pathways is crucial for developing IFN-based cancer therapies.
Purpose of the Study:
- To investigate the effect of IFN-alpha and IFN-gamma on the Stat signaling pathway.
- To utilize a unique human pancreatic carcinoid tumor model (BON cells).
- To elucidate mechanisms of IFN-mediated growth inhibition in endocrine tumors.
Main Methods:
- BON cells were treated with IFN-alpha or IFN-gamma.
- Nuclear proteins were extracted at specific time points.
- Western blot and electrophoretic mobility shift assay (EMSA) were used to measure Stat protein levels and DNA binding.
Main Results:
- IFN-alpha increased Stat3 and Stat5 protein levels and DNA binding.
- IFN-gamma elevated Stat1, Stat3, and Stat5 protein levels within 24-48 hours.
- Both IFNs enhanced Stat3 and Stat5 binding activity to DNA consensus sites.
Conclusions:
- IFN-alpha and IFN-gamma induce Stat protein binding and increase Stat protein levels in BON cells.
- These findings clarify Stat pathway activation by IFNs in endocrine tumors.
- Further research will identify downstream targets and mechanisms of IFN-induced tumor growth inhibition.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...

